Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as a related topic.
    Difference
    0.2%
    Check dated 2026-04-02T15:23:27.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added. Melanoma and related topics (MedlinePlus Genetics) and Revision: v3.4.3 were removed.
    Difference
    0.2%
    Check dated 2026-03-19T04:49:25.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:21.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-03-04T23:43:52.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Melanoma and related topics (MedlinePlus Genetics) were added, and the site revision was updated to v3.4.2 while the prior downtime notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T12:34:40.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operations. Updated the page to Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T07:39:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.